Scenesse (afamelanotide) is an implant that's placed under the skin in adults to treat painful skin reactions from light due to a rare genetic condition called erythropoietic protoporphyria (EPP). It's the first FDA-approved treatment to improve tolerance to light in adults with EPP. It's convenient to use because you only have to get the implant once every 2 months. But it might cause side effects, such as darkening of the skin or freckles. This medication is brand name only so it can be expensive.
Scenesse (afamelanotide) is a man-made form of a natural hormone found in our bodies called alpha-melanocyte stimulating hormone. This hormone raises the level of eumelanin, a pigment in the skin that helps protect your skin against light.
People with EPP are very sensitive to light and experience very painful skin reactions (phototoxicity) under sunlight and some artificial light. By raising the level of eumelanin, Scenesse (afamelanotide) helps people with EPP be less sensitive to light.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Once it's placed under your skin, Scenesse (afamelanotide) is slowly released by the implant over the course of about 2 months. After this time, the implant will dissolve and be absorbed by your body. Then, you'll need to get another Scenesse (afamelanotide) implant placed under your skin by a healthcare provider.
A healthcare provider will place the Scenesse (afamelanotide) implant under your skin above your pelvis in your lower belly (supra-iliac crest).
After you get the Scenesse (afamelanotide) implant placed under your skin, you might be able to feel it or have some skin irritation around where it's placed. If your implant comes out or feels uncomfortable, contact your provider. The implant will slowly dissolve over the course of about 2 months, and you'll need to get a new implant.
While Scenesse (afamelanotide) works to protect your skin from painful reactions due to light, it's still important to protect your skin from the sun because this medication might not prevent all cases of phototoxicity. For people with EPP, wearing protective clothing might be more effective than wearing sunscreen. Examples of protective clothing include wide-brimmed hat, long sleeves, gloves, and long pants.
There isn't enough information to know if Scenesse (afamelanotide) is safe or works well in children. If your child has EPP, speak to your child's provider about treatment options for them.
Scenesse (afamelanotide) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Scenesse (afamelanotide) might lead to darkening of your skin or freckles. It's recommended to get your skin checked twice a year while taking Scenesse (afamelanotide) so your provider can check for any skin changes. Although most colored spots on your skin are harmless, they can sometimes be cancerous so it's important to get them checked. If you notice any new changes on your skin, let your provider know.
Continue to practice sun safety with Scenesse (afamelanotide) to prevent skin reactions. Make sure to wear sunscreen and protective clothing when you go out in the sun.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 16mg | 1 implant | $48,399.05 | $48,399.05 |
A 16 mg Scenesse (afamelanotide) implant is placed into the fatty area above your hip by a healthcare provider every 2 months. The implant slowly releases medication in your body during this time.